Catalyst

Slingshot members are tracking this event:

Mast Therapeutics Receives Notice Of Allowance Of Composition Of Matter Patent Application Covering Vepoloxamer

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
MSTX

100%

Additional Information

Additional Relevant Details The allowed claims cover composition of matter, methods of use, and methods of making certain purified forms of poloxamer 188, including vepoloxamer. The notice of allowance concludes substantive examination of the patent application, which is expected to issue as a patent once the issue fee is paid and the USPTO concludes administrative procedures. Mast also has filed corresponding patent applications that will allow the Company to seek similar patent protection for vepoloxamer in key markets throughout the world, including Europe and Japan.
http://masttherapeut...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 08, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Vepoloxamer, Poloxamer 188